The OTC Drug sector has grown very substantially everywhere in the world as formerly registered drugs come off patent and are found to be safe enough for unsupervised use by consumers. Initially, new OTC products have been invented and distributed globally. Typical categories of such products Anti-Allergy medicines, Pain/Analgesia, Cough/Cold/Flu, Eye Care, Skin Care, Personal Hygiene and Vitamins/Supplements. These products come in many formats such as pills, sprays, creams, ointments, lozenges, quick dissolve film and drops.
Ferghana advises its clients on strategic Partnerships, Acquisitions and Divestments, as well as on creative Financings, since these elements are all critical to the healthy future and growth of OTC Drug companies.
The ‘over the counter’ (OTC) pharmaceuticals market has enjoyed steady growth over the last decade, with sales fueled by a wider range of pharmaceutical products authorized for retail sale, either originating from (a) prescription products (the “RX-to-OTC switch”) for reasons of brand management or of prolonging the life cycle of the product or (b) from an initial intention to create OTC products.